Skip to content

Week on, week off treatment strategy buried at Paris conference

Paris conference hears more bad news on HCV coinfection

Treatment for babies can block HIV breast milk transmission

Long-term maintenance with a single boosted PI

IL-2 and/or therapeutic vaccines for successful treatment interruptions?

MaxCMin2 trial shows lopinavir/ritonavir superior to saquinavir/ritonavir

High pill burden means poorer adherence but adherence no role in viral load blips

Cutting though the bull: TORO at 48 weeks

Low incidence of nevirapine resistance seen in Cameroon women given drug for MTCT